Neurite growth is required for nervous system development and repair. Multiple signals, including neurotrophic factors and intact mechanosensing mechanisms, interact to regulate neurite growth. Degenerin/Epithelial Na 
INTRODUCTION
Neurite growth is required for development of the nervous system, target organ innervation, neural control of organ systems and nerve regeneration following neuronal injury. Neurotrophic factors are well studied regulators of neurite growth and include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 and insulin growth factor (5, 11, 26) . NGF stimulated neurite growth is primarily mediated by activation of high-affinity tyrosine kinase A (TrkA) receptors, and to a smaller extent, activation of low-affinity p75 receptors (3, 8) . However, the down-stream mechanisms by which neurotrophic factors stimulate neurite formation are not fully understood.
One potential mechanism is neurotrophins may induce expression of putative mechanosensory elements, which permit interactions between neurons and their extracellular environment. Three lines of evidence support this possibility. First, mechanosensitive proteins are found at the site of growth in nerve endings and growth cones (4, 25, 27, 28, 43) . Second, normal neurite formation and elongation require activation of mechanosensitive proteins (17, 32, 39) . Third, neurotrophic factors upregulate putative mechanosensory proteins in sensory neurons (7, 29, 30) . These data suggest mechanosensitive elements contribute to neurite growth and may be regulated by neurotrophic factors.
Members of the Degenerin/ Epithelial Na + Channel (DEG/ENaC) protein family have been identified as potential components of mechanosensitive ion channel complexes involved in baroreception, touch sensation and proprioception in sensory neurons (1, 9, (30) . Cultures were then immunostained to detect changes in b and gENaC protein or assayed for neurite growth as described below. used extreme care to maintain uniform experimental conditions. To minimize sampling variability, the following steps were taken. All samples (control and experimental) were 1) run in parallel and treated identically, 2) examined under identical conditions and 3)
Reverse Transcription Polymerase Chain Reaction (RT-PCR
repeated at least three times. Antigen-affinity purified rabbit anti-b and sheep antigENaC antibodies (1:100) have been used previously for immunolabeling (13, 14) .
Rabbit anti-ASIC1 was obtained from Chemicon (Temecula, CA). Cells were plated on collagen coated 8-well glass slides as described and incubated with NGF (10 ng/ml -100 ng/ml) for 24 hours to induce neurite formation. Immediately following, all samples were washed in PBS, fixed in 4% paraformaldehyde for 10 minutes, rinsed with PBS. 
.
Neurite Growth Assay. Neurite growth was assessed using a standard neurite growth assay (23, 24) . PC12 cells were plated on collagen-coated 8 well cover-glass slides as and/or gENaC siRNA or dominant-negative molecules and maintained for 48-72 h.
Neurite formation was induced with NGF (50 ng/ml, 24 h) and assessed using a standard neurite growth assay described.
siRNA. and Dominant-Negative Fusion Molecules. To determine if specific DEG/ENaC
proteins are required for NGF-induced neurite formation, we knocked down message and protein using siRNA and dominant-negative technology. 11 inhibited bENaC immunolabeling at all NGF concentrations. Unexpectedly, p75 receptor blockade at the highest NGF concentration (100 ng/ml) significantly increased NGFinduced gENaC immunofluorescence intensity.
As shown by others, NGF (50 ng/ml, 24 h) induces neurite formation in approximately 40% of cells, which was prevented by TrkA, and to a lesser extent p75, receptor blockade ( Figure 2C ). in NGF-stimulated cells following blockade of ENaC expression using three approaches.
Disruption of ENaC Activity Prevents
In the first approach, we blocked channel activity with benzamil (100 nM -10 mM)
specific ENaC inhibitor at low doses. In the second and third approaches, we blocked transcript and protein expression using b and gENaC siRNA and dominant-negative 
